PURMX Therapeutics
Developer of a silver bullet and nucleic acid drug intended for malignant pleural mesothelioma. The company creates innovative nucleic acid drugs to save patients suffering from intractable diseases a...
Valuation
$0
Share Price
N/A
Total Raised
$6.6M
Last Round
N/A